Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na⁺ excretion and insulin resistance

References

• Plana E, Oto J, Medina P, Herranz R, Fernández-Pardo Á, Requejo L, Miralles M. Thrombospondins in human aortic aneurysms. Iubmb Life. 2022;74(10):982–8. doi:10.1002/iub.2610.
   PubMed Web of Science ®Google Scholar
• Kassem MM, Helkin A, Maier KG, Gahtan V. Thrombospondins differentially regulate proteins involved in arterial remodeling. Physiol Res. 2019;68:893–900. doi:10.33549/physiolres.934148.
   PubMed Web of Science ®Google Scholar
• Adams JC, Lawler J. The thrombospondins. Cold Spring Harb Perspect Biol. 2011;3(10):a009712. doi:10.1101/cshperspect.a009712.
   PubMed Web of Science ®Google Scholar
• Carminati L, Taraboletti G. Thrombospondins in bone remodeling and metastatic bone disease. Am J Physiol Cell Physiol. 2020;319(6):C980–c990. doi:10.1152/ajpcell.00383.2020.
   PubMed Web of Science ®Google Scholar
• Zhao C, Isenberg JS, Popel AS. Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions. J Cell Mol Med. 2018;22(4):2086–97. doi:10.1111/jcmm.13565.
   PubMed Web of Science ®Google Scholar
• Kaur S, Roberts DD. Why do humans need thrombospondin-1? J Cell Commun Signal. 2023;17(3):485–93. doi:10.1007/s12079-023-00722-5.
   PubMed Web of Science ®Google Scholar
• Morandi V, Petrik J, Lawler J. Endothelial cell behavior is determined by receptor clustering induced by thrombospondin-1. Front Cell Dev Biol. 2021;9:664696. doi:10.3389/fcell.2021.664696.
   PubMed Web of Science ®Google Scholar
• Gutierrez LS, Gutierrez J. Thrombospondin 1 in metabolic diseases. Front Endocrinol (Lausanne). 2021;12:638536. doi:10.3389/fendo.2021.638536.
   PubMed Web of Science ®Google Scholar
• Lawler J. The functions of thrombospondin-1 and-2. Curr Opin Cell Biol. 2000;12(5):634–40. doi:10.1016/s0955-0674(00)00143-5.
   PubMed Web of Science ®Google Scholar
• Zhang K, Li M, Yin L, Fu G, Liu Z. Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (review). Int J Mol Med. 2020;45:1275–93. doi:10.3892/ijmm.2020.4507.
   PubMed Web of Science ®Google Scholar
• Forbes T, Pauza AG, Adams JC. In the balance: how do thrombospondins contribute to the cellular pathophysiology of cardiovascular disease? Am J Physiol Cell Physiol. 2021;321(5):C826–c845. doi:10.1152/ajpcell.00251.2021.
   PubMed Web of Science ®Google Scholar
• Kilic T, Okuno K, Eguchi S, Kassiri Z. Disintegrin and metalloproteinases (ADAMs [A disintegrin and metalloproteinase] and ADAMTSs [ADAMs with a thrombospondin motif]) in aortic aneurysm. Hypertension. 2022;79(7):1327–38. doi:10.1161/hypertensionaha.122.17963.
   PubMed Web of Science ®Google Scholar
• Chandran S, Watkins J, Abdul-Aziz A, Shafat M, Calvert PA, Bowles KM, Flather MD, Rushworth SA, Ryding AD. Inflammatory differences in plaque erosion and rupture in patients with ST-segment elevation myocardial infarction. J Am Heart Assoc. 2017;6(5):6. doi:10.1161/jaha.117.005868.
   Web of Science ®Google Scholar
• Bauer EM, Qin Y, Miller TW, Bandle RW, Csanyi G, Pagano PJ, Bauer PM, Schnermann J, Roberts DD, Isenberg JS. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res. 2010;88(3):471–81. doi:10.1093/cvr/cvq218.
   PubMed Web of Science ®Google Scholar
• Isenberg JS, Qin Y, Maxhimer JB, Sipes JM, Despres D, Schnermann J, Frazier WA, Roberts DD. Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol. 2009;28(2):110–19. doi:10.1016/j.matbio.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Armstrong LC, Björkblom B, Hankenson KD, Siadak AW, Stiles CE, Bornstein P, Heldin C-H. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism. Mol Biol Cell. 2002;13(6):1893–905. doi:10.1091/mbc.e01-09-0066.
   PubMed Web of Science ®Google Scholar
• Panetti TS, Chen H, Misenheimer TM, Getzler SB, Mosher DF. Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med. 1997;129(2):208–16. doi:10.1016/s0022-2143(97)90141-4.
   PubMed Web of Science ®Google Scholar
• Smeriglio P, Wangsawihardja FV, Leu R, Mustapha M. TSP1 and TSP2 have unique and overlapping roles in protecting against noise-induced auditory synaptopathy. Neuroscience. 2019;408:68–80. doi:10.1016/j.neuroscience.2019.03.036.
   PubMed Web of Science ®Google Scholar
• Koch M, Hussein F, Woeste A, Gründker C, Frontzek K, Emons G, Hawighorst T. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Breast Cancer Res Treat. 2011;128(2):337–46. doi:10.1007/s10549-010-1085-7.
   PubMed Web of Science ®Google Scholar
• Oguri M, Kato K, Yokoi K, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Nishigaki Y, Yoshida H, et al. Association of polymorphisms of THBS2 and HSPA8 with hypertension in Japanese individuals with chronic kidney disease. Mol Med Rep. 2009;2(2):205–11. doi:10.3892/mmr_00000085.
   PubMed Web of Science ®Google Scholar
• Kato K, Oguri M, Kato N, Hibino T, Yajima K, Yoshida T, Metoki N, Yoshida H, Satoh K, Watanabe S, et al. Assessment of genetic risk factors for thoracic aortic aneurysm in hypertensive patients. Am J Hypertens. 2008;21(9):1023–27. doi:10.1038/ajh.2008.229.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li H, Ma Y, Zhu X, Zhang S, Li J. MiR-221-3p is down-regulated in preeclampsia and affects trophoblast growth, invasion and migration partly via targeting thrombospondin 2. Biomed Pharmacother. 2019;109:127–34. doi:10.1016/j.biopha.2018.10.009.
   PubMed Web of Science ®Google Scholar
• 2018 Chinese guidelines for prevention and treatment of hypertension-A report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241. doi:10.11909/j.issn.1671-5411.2019.03.014.
   PubMedGoogle Scholar
• O’Donnell M, Mente A, Alderman MH, Brady AJB, Diaz R, Gupta R, López-Jaramillo P, Luft FC, Lüscher TF, Mancia G, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. Eur Heart J. 2020;41(35):3363–73. doi:10.1093/eurheartj/ehaa586.
   PubMed Web of Science ®Google Scholar
• Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8. doi:10.1186/s12933-019-0982-2.
   PubMed Web of Science ®Google Scholar
• Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan TJE, Harbuwono DS, Purnamasari D, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr. 2022;16(8):102581. doi:10.1016/j.dsx.2022.102581.
   PubMedGoogle Scholar
• Brands MW. Role of insulin-mediated antinatriuresis in sodium homeostasis and hypertension. Hypertension. 2018;72(6):1255–62. doi:10.1161/hypertensionaha.118.11728.
   PubMed Web of Science ®Google Scholar
• Rucker AJ, Rudemiller NP, Crowley SD. Salt, hypertension, and immunity. Annu Rev Physiol. 2018;80(1):283–307. doi:10.1146/annurev-physiol-021317-121134.
   PubMedGoogle Scholar
• Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis. Clin Chim Acta. 2017;464:57–63. doi:10.1016/j.cca.2016.11.009.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu F, Zhang Y, Lu Y, Su Z, Ji H, Cheng Y, Song W, Hidru TH, Yang X, et al. The relationship of endothelial function and arterial stiffness with subclinical target organ damage in essential hypertension. J Clin Hypertens. 2022;24(4):418–29. doi:10.1111/jch.14447.
   Web of Science ®Google Scholar
• Bruno AS, Lopes PDD, de Oliveira KCM, de Oliveira AK, de Assis Cau SB. Vascular inflammation in hypertension: targeting lipid mediators unbalance and nitrosative stress. Curr Hypertens Rev. 2021;17(1):35–46. doi:10.2174/1573402116666191220122332.
   PubMed Web of Science ®Google Scholar
• Boban M, Kocic G, Radenkovic S, Pavlovic R, Cvetkovic T, Deljanin-Ilic M, Ilic S, Bobana MD, Djindjic B, Stojanovic D, et al. Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease. Ren Fail. 2014;36(4):613–18. doi:10.3109/0886022x.2014.882240.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV, Orekhov AN. Thrombospondins: a role in cardiovascular disease. Int J Mol Sci. 2017;18(7):1540. doi:10.3390/ijms18071540.
   PubMed Web of Science ®Google Scholar
• Frame AA, Wainford RD. Mechanisms of altered renal sodium handling in age-related hypertension. Am J Physiol Renal Physiol. 2018;315(1):F1–f6. doi:10.1152/ajprenal.00594.2017.
   PubMed Web of Science ®Google Scholar
• Horita S, Nakamura M, Suzuki M, Satoh N, Suzuki A, Homma Y, Nangaku M. The role of renal proximal tubule transport in the regulation of blood pressure. Kidney Res Clin Pract. 2017;36(1):12–21. doi:10.23876/j.krcp.2017.36.1.12.
   PubMedGoogle Scholar
• Inoue M, Jiang Y, Barnes RH 2nd, Tokunaga M, Martinez-Santibañez G, Geletka L, Lumeng CN, Buchner DA, Chun TH. Thrombospondin 1 mediates high-fat diet-induced muscle fibrosis and insulin resistance in male mice. Endocrinology. 2013;154(12):4548–59. doi:10.1210/en.2013-1587.
   PubMed Web of Science ®Google Scholar
• Simantov R, Febbraio M, Silverstein RL. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Matrix Biol. 2005;24(1):27–34. doi:10.1016/j.matbio.2004.11.005.
   PubMed Web of Science ®Google Scholar
• Wong YH, Wong SH, Wong XT, Yap QY, Yip KY, Wong LZ, Chellappan DK, Bhattamisra SK, Candasamy M. Genetic associated complications of type 2 diabetes mellitus. Panminerva Med. 2022;64(2):274–88. doi:10.23736/s0031-0808.21.04285-3.
   PubMed Web of Science ®Google Scholar
• Daniel C, Amann K, Hohenstein B, Bornstein P, Hugo C. Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice. J Am Soc Nephrol. 2007;18(3):788–98. doi:10.1681/asn.2006080873.
   PubMed Web of Science ®Google Scholar
• da Silva AA, Do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82. doi:10.1016/j.cjca.2020.02.066.
   PubMed Web of Science ®Google Scholar
• Van Hul M, Frederix L, Lijnen HR. Role of thrombospondin-2 in murine adipose tissue angiogenesis and development. Obesity (Silver Spring). 2012;20(9):1757–62. doi:10.1038/oby.2011.260.
   PubMed Web of Science ®Google Scholar
• Wu X, Cheung CKY, Ye D, Chakrabarti S, Mahajan H, Yan S, Song E, Yang W, Lee CH, Lam KSL, et al. Serum thrombospondin-2 levels are closely associated with the severity of metabolic syndrome and metabolic associated fatty liver disease. J Clin Endocrinol Metab. 2022;107(8):e3230–e40. doi:10.1210/clinem/dgac292.
   PubMed Web of Science ®Google Scholar
• Konukoglu D, Uzun H. Endothelial dysfunction and hypertension. Adv Exp Med Biol. 2017;956:511–40. doi:10.1007/5584_2016_90.
   PubMed Web of Science ®Google Scholar
• Bartoli F, Debant M, Chuntharpursat-Bon E, Evans EL, Musialowski KE, Parsonage G, Morley LC, Futers TS, Sukumar P, Bowen TS, et al. Endothelial Piezo1 sustains muscle capillary density and contributes to physical activity. J Clin Invest. 2022;132(5). doi:10.1172/jci141775.
   PubMed Web of Science ®Google Scholar
• Noh YH, Matsuda K, Hong YK, Kunstfeld R, Riccardi L, Koch M, Oura H, Dadras SS, Streit M, Detmar M. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo. J Invest Dermatol. 2003;121(6):1536–43. doi:10.1046/j.1523-1747.2003.12643.x.
   PubMed Web of Science ®Google Scholar
• Shitaye HS, Terkhorn SP, Combs JA, Hankenson KD. Thrombospondin-2 is an endogenous adipocyte inhibitor. Matrix Biol. 2010;29(6):549–56. doi:10.1016/j.matbio.2010.05.006.
   PubMed Web of Science ®Google Scholar